Search research articles
Contact Us
Filters
Showing results (1-10 of 139) with videos related to
Page
of 14
Sort By:
Urologie (Heidelberg, Germany)
|
May 18, 2026
[Oligometastatic hormone-sensitive prostate cancer: when can less be more?]
Richard Cathomas
European Journal of Cancer (Oxford, England : 1990)
|
November 4, 2020
Treading carefully in de-escalation for bone-targeted agents - is less more, after all?
Anna Patrikidou, Richard Cathomas
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 28, 2019
Reply to V. Murthy et al
Richard Cathomas, Jörg Beyer
European Urology
|
May 20, 2025
Re: Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results from the Prospective BladderPath Trial
Christian Daniel Fankhauser, Richard Cathomas
European Journal of Dermatology : EJD
|
February 14, 2009
"Skin problems associated with pegylated liposomal doxorubicin -- more than palmoplantar erythrodysesthesia syndrome"
Roger Von Moos, Richard Cathomas
Oncology Research and Treatment
|
September 12, 2016
Multitargeted Kinase Inhibition in Metastatic Differentiated Radioiodine-Refractory Thyroid Cancer: A Look at New Therapeutic Options for a Rare Disease
Katharina Mischler, Stefan Kneifel, Richard Cathomas
The Lancet. Oncology
|
February 1, 2023
Is chemoradiotherapy worth it in metastatic seminoma as first-line treatment? - Authors' reply
Alexandros Papachristofilou, Stefanie Hayoz, Richard Cathomas
The New England Journal of Medicine
|
November 7, 2007
Drug-induced immune thrombocytopenia
Richard Cathomas, Aron Goldhirsch, Roger von Moos
The Lancet. Oncology
|
September 3, 2021
Pembrolizumab monotherapy for high-risk, non-muscle-invasive bladder cancer
Cyrill A Rentsch, Stefanie Hayoz, Richard Cathomas
BMJ Case Reports
|
January 21, 2019
Hypokalaemic metabolic alkalosis, hypertension and diabetes: what is the link
Marius Vögelin, Richard Cathomas, Niklaus Kamber, et al.
Page
of 14
Search research articles
Search
Showing results (1-10 of 139) with videos related to
Sort By:
Page
of 14
Urologie (Heidelberg, Germany)
|
May 18, 2026
[Oligometastatic hormone-sensitive prostate cancer: when can less be more?]
Richard Cathomas
European Journal of Cancer (Oxford, England : 1990)
|
November 4, 2020
Treading carefully in de-escalation for bone-targeted agents - is less more, after all?
Anna Patrikidou, Richard Cathomas
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 28, 2019
Reply to V. Murthy et al
Richard Cathomas, Jörg Beyer
European Urology
|
May 20, 2025
Re: Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results from the Prospective BladderPath Trial
Christian Daniel Fankhauser, Richard Cathomas
European Journal of Dermatology : EJD
|
February 14, 2009
"Skin problems associated with pegylated liposomal doxorubicin -- more than palmoplantar erythrodysesthesia syndrome"
Roger Von Moos, Richard Cathomas
Oncology Research and Treatment
|
September 12, 2016
Multitargeted Kinase Inhibition in Metastatic Differentiated Radioiodine-Refractory Thyroid Cancer: A Look at New Therapeutic Options for a Rare Disease
Katharina Mischler, Stefan Kneifel, Richard Cathomas
The Lancet. Oncology
|
February 1, 2023
Is chemoradiotherapy worth it in metastatic seminoma as first-line treatment? - Authors' reply
Alexandros Papachristofilou, Stefanie Hayoz, Richard Cathomas
The New England Journal of Medicine
|
November 7, 2007
Drug-induced immune thrombocytopenia
Richard Cathomas, Aron Goldhirsch, Roger von Moos
The Lancet. Oncology
|
September 3, 2021
Pembrolizumab monotherapy for high-risk, non-muscle-invasive bladder cancer
Cyrill A Rentsch, Stefanie Hayoz, Richard Cathomas
BMJ Case Reports
|
January 21, 2019
Hypokalaemic metabolic alkalosis, hypertension and diabetes: what is the link
Marius Vögelin, Richard Cathomas, Niklaus Kamber, et al.
Page
of 14